Elan plans $1 bln buyback and acquisitions

Irish drugmaker Elan will return $1 billion to shareholders and seek acquisitions with the proceeds of selling its stake in blockbuster multiple sclerosis (MS) treatment Tysabri to partner Biogen Idec. The sale

Thousands protest in Armenia after president re-elected

About 5,000 flag-waving protesters rallied on Wednesday against Armenian President Serzh Sarksyan's re-election, saying his victory was tainted by fraud. Supporters of Sarksyan's second-placed rival Raffi Hovannisian filled Freedom Square in the

Asda sales growth slows in UK

Asda, the British arm of U.S. retailer Wal-Mart, said underlying sales growth had slowed in the fourth quarter of its financial year as consumers tightened spending. Britain's second-biggest supermarket chain behind Tesco